Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
LG CNS expands AI transformation push into pharma, biotech
LG CNS, an IT services and digital transformation arm of LG Group, is expanding its artificial intelligence (AI) business into the pharmaceutical and biotechnology sector, securing a large-scale contract for a government-led drug R&D initiative and…
Another alliance of health care and AI signals why pharma stocks should be back in favor
Bristol Myers Squibb and Microsoft 's new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with…
How China Became the Biotech Industry's Back-Office
For years, public debate around U.S. dependence on China has focused on semiconductors, consumer electronics, rare earth minerals and industrial manufacturing. Far less attention has been paid to a quieter—but arguably more consequential…
15 minutes saved ₹2.16 crore: How a Bengaluru pharma firm used 'golden hour' to outsmart a Nigerian email spoofing scam
The Central Crime Branch (CCB) in Bengaluru has unearthed a major email spoofing fraud involving the diversion of ₹2.16 crore through fake bank accounts, linked to Nigeria. According to the Bengaluru police, cybercriminals operating from…
Torrent Pharma acquires 46.39% stake in JB Chemicals; CEO to step down
Torrent Pharmaceuticals has been formally recognised as the new promoter of Mumbai-based JB Chemicals & Pharmaceuticals, after completing the acquisition of a 46.39 per cent stake in the company. The move has triggered a change of control, a…
Enterprise Content and Marketing Trends: Insights for 2026
Most of my career, I've heard smaller companies wistfully say: “If only we were bigger.” Bigger budgets. Bigger teams. Bigger tech stacks. Bigger everything. There's this almost fairy-tale belief that once you cross some mythical…
Patient Capital Management LLC Boosts Stake in Royalty Pharma PLC $RPRX
Patient Capital Management LLC boosted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 4.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The…
The 'sell America' trade, Trump arrives in Davos, Netflix earnings and more in Morning Squawk
This is CNBC's Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Wednesday. Or maybe not, if you held U.S. assets amid yesterday's sell-off. S&P 500 futures are little changed this morning. The three major…
Healthy Returns: Structure Therapeutics CEO on its obesity pill, combinations and future of GLP-1s
Benjamin Fanjoy | Bloomberg | Getty Images A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. After the launch…
Jim Cramer's top 10 things to watch in the stock market Wednesday
My top 10 things to watch Wednesday, Jan. 21 1. Stocks fell again early this morning after the market's biggest selloff in three months. The S & P 500 and Nasdaq both had their worst sessions since Oct. 10, bringing both indexes into negative…
Amgen downgraded at Bernstein on 2026 outlook (AMGN:NASDAQ)
Bernstein has downgraded Amgen (AMGN) to Market Perform from Outperform, arguing that 2026 could be a “waiting year” for the pharma giant and its stock will remain within 15% of its $335 per share target for the rest of the year.
Nifty Prediction Today - January 21, 2026: Nifty futures: Sellers dominate
Nifty 50 opened today's session with a gap-down at 25,141 versus yesterday's close of 25,233. It is now hovering around 25,160, down 0.25 per cent. Tata Motors Passenger Vehicles (TMPV) tops the chart in Nifty 50 by advancing 1.4 per cent. This is…
OpenAI's CFO laid out new revenue sources to fund all that compute
OpenAI CFO Sarah Friar sketched a future in which the company's business models evolve beyond subscriptions and could include royalty streams tied to customer results. Speaking on a recent podcast, Friar floated the possibility of 'licensing…
PraxisPro raises $6M seed from AlleyCorp to coach medical sales reps
It all began in sales. That's where Cam Badger got his start, at a pharmaceutical company. He expected to find structure and mentorship on the job but instead found “fragmented training, inconsistent coaching, and no real way to scale…
Karolinska Development's portfolio company Dilafor signs binding term sheet with Exeltis for a license agreement regarding tafoxiparin
STOCKHOLM, SWEDEN – January 21, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has signed a binding term sheet with Exeltis, a global Women's Health company, for an exclusive…
Receive a Daily briefing on Pharma Industry News
Get Started